Literature DB >> 22977634

Relationship of ovarian volume with mean platelet volume and lipid profile in patients with polycystic ovary syndrome.

Nermin Köşüş1, Aydin Köşüş, Nilgün Ö Turhan.   

Abstract

The aim of the present study was to evaluate the relationship between ovarian volume (OV) and mean platelet volume (MPV) in women with polycystic ovary syndrome (PCOS). Hormonal parameters and lipid profile of cases, and their relationship to OV were also assessed. Bilateral OV of 210 newly diagnosed PCOS patients and 100 healthy non-hirsute women were measured by ultrasonography. Blood samples were obtained for full blood count, hormone levels and for lipid profiles. It was found that MPV increased gradually as OV increased. This implies a higher risk of hypercoagulability and therefore an increased risk of future cardiovascular disease.

Entities:  

Year:  2011        PMID： 22977634      PMCID： PMC3440831          DOI： 10.3892/etm.2011.327

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN： 1792-0981            Impact factor:   2.447


  21 in total

1.  Mean platelet volume in patients with polycystic ovary disease.

Authors:  Alptekin Gursoy; Derun Taner Ertugrul; Baris Pamuk; Mustafa Sahin; Mehmet Asik; Hamiyet Yilmaz; Filiz Haydardedeoglu; Neslihan Bascil Tutuncu; Nilgun Guvener Demirag
Journal:  Platelets       Date:  2006-11       Impact factor: 3.862

2.  Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.

Authors:  Joan C Lo; Seth L Feigenbaum; Jingrong Yang; Alice R Pressman; Joe V Selby; Alan S Go
Journal:  J Clin Endocrinol Metab       Date:  2006-01-24       Impact factor: 5.958

3.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  Altered vascular function in young women with polycystic ovary syndrome.

Authors:  Christopher J G Kelly; Angela Speirs; Gwyn W Gould; John R Petrie; Helen Lyall; John M C Connell
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

Review 5.  Polycystic ovary syndrome.

Authors:  Roy Homburg
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2007-09-05       Impact factor: 5.237

6.  High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome.

Authors:  Levent Kebapcilar; Cuneyt Eftal Taner; Ayse Gul Kebapcilar; Ismail Sari
Journal:  Arch Gynecol Obstet       Date:  2008-12-24       Impact factor: 2.344

7.  The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration.

Authors:  J F Martin; E A Trowbridge; G Salmon; J Plumb
Journal:  Thromb Res       Date:  1983-12-01       Impact factor: 3.944

8.  Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.

Authors:  Levent Kebapcilar; Cuneyt Eftal Taner; Ayse Gul Kebapcilar; Ahmet Alacacioglu; Ismail Sari
Journal:  Arch Gynecol Obstet       Date:  2009-03-28       Impact factor: 2.344

9.  Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.

Authors:  Sharmalar Rajendran; Scott R Willoughby; Wai Ping A Chan; Elizabeth A Liberts; Tamila Heresztyn; Mrinal Saha; Michael S Marber; Robert J Norman; John D Horowitz
Journal:  Atherosclerosis       Date:  2008-09-17       Impact factor: 5.162

10.  Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome.

Authors:  Z Puzigaća; G M Prelević; Z Stretenović; L Balint-Perić
Journal:  Gynecol Endocrinol       Date:  1991-09       Impact factor: 2.260
View more
  7 in total

1.  Decreased mean platelet volume is associated with the developing stage of fetoplacental unit in spontaneous abortion.

Authors:  Mustafa Kaplanoglu; Tuncay Yuce; Mehmet Bulbul
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.

Authors:  Y Çakıroğlu; F Vural; B Vural
Journal:  J Endocrinol Invest       Date:  2016-03-15       Impact factor: 4.256

3.  Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia.

Authors:  Semra Aktürk; Raikan Büyükavcı
Journal:  Clin Rheumatol       Date:  2017-05-02       Impact factor: 2.980

4.  Mean platelet volume in patients with fibromyalgia.

Authors:  S Haliloğlu; A Carlioglu; E Sahiner; Y Karaaslan; A Kosar
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

5.  Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women.

Authors:  Simona Ianoşi; Gabriel Ianoşi; Daniela Neagoe; Oana Ionescu; Ovidiu Zlatian; Anca Oana Docea; Corin Badiu; Maria Sifaki; Dimitris Tsoukalas; Aristidis M Tsatsakis; Demetrios A Spandidos; Daniela Călina
Journal:  Mol Med Rep       Date:  2016-11-04       Impact factor: 2.952

6.  Mean platelet volume and polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Li Li; Jianxiu Yu; Zhongwei Zhou
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

7.  Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome.

Authors:  Dilek Benk Silfeler; Raziye Keskin Kurt; Erhan Yengil; Burak Un; Secil Arica; Ali Baloglu
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.